Sagimet Biosciences (SGMT) Non-Current Assets (2022 - 2026)
Sagimet Biosciences (SGMT) recorded quarterly Non-Current Assets of $39000.0 in Q1 2026, down 50.0% quarter-over-quarter from $78000.0 in Q4 2025, and down 61.0% on a YoY basis from $100000.0 in Q1 2025.
Sagimet Biosciences (SGMT) Non-Current Assets (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Non-Current Assets history runs 5 years deep, the most recent figure standing at $39000.0 for Q1 2026.
- In Q1 2026, Non-Current Assets fell 61.0% year-over-year to $39000.0; the TTM figure through Mar 2026 stood at $19.2 million (down 59.42% YoY), while the FY2025 annual figure was $78000.0, down 98.96% from the prior year.
- Non-Current Assets was $39000.0 for Q1 2026 at Sagimet Biosciences, down from $78000.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $22.3 million in Q2 2024 to a low of $37000.0 in Q1 2024.
- Historically, Non-Current Assets has averaged $5.2 million across 5 years, with a median of $144000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets jumped 16033.03% in 2024, then sank 98.96% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $239000.0 in 2022, then slumped by 69.46% to $73000.0 in 2023, then jumped by 10153.42% to $7.5 million in 2024, then tumbled by 98.96% to $78000.0 in 2025, then tumbled by 50.0% to $39000.0 in 2026.
- The last three Non-Current Assets figures came in at $39000.0 (Q1 2026), $78000.0 (Q4 2025), and $8.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 62,953.78 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 39.71 Mn |
| 10 | Sagimet Biosciences | 211.96 Mn | 211.96 Mn | - | 39,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Sep 30, 2025 | 8.92 Mn |
| Jun 30, 2025 | 10.21 Mn |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 7.49 Mn |
| Sep 30, 2024 | 17.59 Mn |
| Jun 30, 2024 | 22.27 Mn |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Sep 30, 2023 | 109,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Dec 31, 2022 | 239,000.00 |